Drugs / XingpiJieyu Formula
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT07590609 | May 2023 → Jan 2026 | major depressive disorder | Peking University Sixth Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06758167 | Nov 2020 → Apr 2024 | major depressive disorder | Peking University Sixth Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xingpi Jieyu Formula | “adding Xingpi Jieyu Formula (a traditional Chinese herbal granule) to the standard antidepressant escitalopram” NCT07590609 ↗ |
| Known as | XPJYF | “XingpiJieyu Formula (XPJYF): Traditional Chinese medicine herbal granules.” NCT07590609 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “XingpiJieyu formula is a traditional Chinese medicine.” NCT06758167 ↗ |
| Route | Oral | “taken orally” NCT07590609 ↗ |